High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The aim of this study is the safety and efficacy of high-activity natural killer immunotherapy to small metastases of pancreatic cancer.
Epistemonikos ID: 0fbd2988cfda620d7ef2e71880ac2046a86afdfc
First added on: May 20, 2024